Attention deficit and hyperactivity disorder, methylphenidate, and epilepsy.
about
Utility of the Electroencephalogram in Attention Deficit Hyperactivity DisorderSafety of stimulant treatment in attention deficit hyperactivity disorder: part II.Adaptive phase I study of OROS methylphenidate treatment of attention deficit hyperactivity disorder with epilepsy.One-year prospective follow-up of pharmacological treatment in children with attention-deficit/hyperactivity disorder.Methylphenidate treatment of attention deficit hyperactivity disorder in young people with learning disability and difficult-to-treat epilepsy: evidence of clinical benefitMethylphenidate HCl: therapy for attention deficit hyperactivity disorder.Adverse reactions of Methylphenidate in children with attention deficit-hyperactivity disorder: Report from a referral center.Effects of hippotherapy on brain function, BDNF level, and physical fitness in children with ADHDEvidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology.Epilepsy, Attention-Deficit/Hyperactivity Disorder and Methylphenidate: Critical Examination of Guiding Evidence[Formula: see text]Differences in memory functioning between children with attention-deficit/hyperactivity disorder and/or focal epilepsy.Attention-deficit disorders and epilepsy in childhood: incidence, causative relations and treatment possibilities.Methylphenidate, cognition, and epilepsy: A double-blind, placebo-controlled, single-dose study.Evaluation of attention-deficit hyperactivity disorder risk factors.Association between attention-deficit/hyperactivity disorder and epilepsy in pediatric populations.Prevalence of epilepsy and attention-deficit hyperactivity (ADHD) disorder: a population-based study.Methylphenidate, cognition, and epilepsy: A 1-month open-label trial.Frequency of epileptiform discharges in the sleep-deprived electroencephalogram in children evaluated for attention-deficit disorders.Neuropsychiatric disorders in males with duchenne muscular dystrophy: frequency rate of attention-deficit hyperactivity disorder (ADHD), autism spectrum disorder, and obsessive--compulsive disorder.Quantitative EEG and Current Source Density Analysis of Combined Antiepileptic Drugs and Dopaminergic Agents in Genetic Epilepsy: Two Case Studies.
P2860
Q22241782-DDBCED87-6667-41B4-A97C-45234643B25AQ30451303-2CBAF658-3D4D-4BD9-9D8F-093E6568EC7BQ33987476-5CDD6C1E-3FDC-4F40-B4EF-F5941B33C62FQ34182040-62F7062E-BB5E-498C-9A4C-5D077FF69690Q34402618-887FFC65-9CC2-4BFE-B728-FF15E7C03F9EQ34424163-A7E0BB84-A32D-4E91-B0D2-A1B06DDF5502Q34675680-7F2648F0-D331-445C-A91D-89AE3A443E29Q35913137-BEBB0C63-01ED-4D21-B58A-E4D5B6C12E6EQ36648476-F1E050DF-B885-4F14-9FA2-55FE461C871AQ36685077-C612BDDB-68E2-4DAD-97EC-3BDC2760A63AQ37312006-F26F2F4A-E563-4384-AA68-2AFCF36CC010Q37505713-D6F23A25-86A7-4F9E-B19B-AD7056A78A3AQ38383007-5F586296-702B-4C98-8FF1-0E0D83479958Q41960427-D92931C5-AAC4-4152-9F92-25C6413E3C42Q43232951-C04EA845-11D4-4795-92A0-606360692EEEQ44840473-98BA4D3B-8E57-44F7-A6E7-106FBDC4F273Q46739996-D9842965-E1E9-41CE-9728-94F1E7AB11AEQ48087273-C0FCD027-21FD-444D-A129-29BA52D76508Q50310319-14E14201-27BE-4F4F-A7AE-D2EFD9F25DD3Q50617250-EA3A3EFB-30D1-44D9-A519-79083F618EFE
P2860
Attention deficit and hyperactivity disorder, methylphenidate, and epilepsy.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Attention deficit and hyperactivity disorder, methylphenidate, and epilepsy.
@ast
Attention deficit and hyperactivity disorder, methylphenidate, and epilepsy.
@en
Attention deficit and hyperactivity disorder, methylphenidate, and epilepsy.
@nl
type
label
Attention deficit and hyperactivity disorder, methylphenidate, and epilepsy.
@ast
Attention deficit and hyperactivity disorder, methylphenidate, and epilepsy.
@en
Attention deficit and hyperactivity disorder, methylphenidate, and epilepsy.
@nl
prefLabel
Attention deficit and hyperactivity disorder, methylphenidate, and epilepsy.
@ast
Attention deficit and hyperactivity disorder, methylphenidate, and epilepsy.
@en
Attention deficit and hyperactivity disorder, methylphenidate, and epilepsy.
@nl
P2860
P356
P1476
Attention deficit and hyperactivity disorder, methylphenidate, and epilepsy.
@en
P2093
P2860
P356
10.1136/ADC.2003.048504
P407
P577
2005-01-01T00:00:00Z